Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide Read the full story
Tag Archive | "Abbott"
Zoetis acquires Abbott animal health assets
Posted on 18 November 2014
Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million Read the full story
Abbott announces acquisition of Topera for $250 million
Posted on 30 October 2014
Abbott has entered into an acquisition agreement to purchase Topera. Read the full story
ABL and Abbott sign a biotech deal for HIV genotyping analysis
Posted on 16 September 2014
Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis. Read the full story
Banyan Biomarkers signs pharma licensing deal with Abbott
Posted on 29 August 2014
Banyan Biomarkers has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification .
The terms of the in a pharma licensing agreement were not disclosed. Read the full story
Big pharma, Mylan, buys generic business from Abbott
Posted on 15 July 2014
Mylan, big pharma, will acquire Abbott's non-U.S. developed markets specialty and branded generics business ("the Assets") in an all-stock transaction. Read the full story
Big pharma, Abbott, signs a joint venture with Fonterra
Posted on 14 July 2014
New Zealand’s Fonterra and Abbott, the US big pharma and health care giant are to develop a dairy farm hub in China. Read the full story
Abbvie chases Shire again
Posted on 01 July 2014
The boss of US drug-maker AbbVie is flying into London this week to court Shire’s shareholders and try to convince them of the merits of a potential takeover. Read the full story
M&A news: Abbott to acquire Veropharm for $495 million
Posted on 24 June 2014
In today's m&a news, Abbott announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Read the full story
Abbvie: A new company holding its own in the competitive world of pharma
Posted on 15 June 2014
Abbvie is a global pharmaceutical company developing life saving products for a number of major diseases including immunology. Read the full story
